PHARMACEUTICAL COMPOSITIONS COMPRISING HMG-COA REDUCTASE INHIBITORS IN COMBINATION WITH PHOSPHODIESTERASE-4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASE
- 专利权人:
- NYCOMED GMBH
- 发明人:
- 申请号：
- IL19543308
- 公开号：
- IL195433A
- 申请日:
- 2008.11.23
- 申请国别(地区):
- IL
- 年份:
- 2013
- 代理人:
- 摘要：
- The invention relates to the combined use of a PDE4 inhibitor with a HMG-CoA reductase inhibitor for the preventive and curative treatment of an inflammatory pulmonary disease, wherein the PDE4 inhibitor is selected from the group consisting of ROFLUMILAST, a pharmaceutically acceptable salt of ROFLUMILAST, ROFLUMILAST-N-oxide and a pharmaceutically acceptable salt of ROFLUMILAST-N-oxide, the HMG-CoA reductase inhibitor is ROSUVASTATIN or a pharmaceutically acceptable salt thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- PHARMACEUTICAL COMPOSITIONS COMBINATIONS AND KITS COMPRISING HMG-COA REDUCTASE INHIBITORS IN COMBINATION WITH PHOSPHODIESTERASE-4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASE
- PHARMACEUTICAL COMPOSITIONS COMBINATIONS AND KITS COMPRISING HMG-COA REDUCTASE INHIBITORS IN COMBINATION WITH PHOSPHODIESTERASE-4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASE
- COMBINATION OF HMG-COA REDUCTASE INHIBITORS WITH PHOSPHODIESTERASE 4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASES
- COMBINATION OF HMG-COA REDUCTASE INHIBITORS ATORVASTATIN OR SIMVASTATIN WITH A PHOSPHODIESTERASE 4 INHIBITOR, SUCH AS ROFLUMILAST FOR THE TREATMENT OF INFLAMMATORY PULMONARY DISEASES
- Combination of HMG-CoA reductase inhibitors atorvastatin or simvastatin with a phosphodiesterase 4 inhibitor such as roflumilast for the treatment of inflammatory pulmonary diseases
